New and emerging therapies for lymphedema: Part II

Robert C. Sibley; Stanley G. Rockson

doi:10.1007/978-3-030-93039-4_27

New and emerging therapies for lymphedema: Part II

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The roles of inflammation, fibrosis, and adipose deposition in response to lymph stasis are critical to understanding the pathogenesis of lymphedema. This chapter reviews our current understanding of the key targets in the inflammatory and fibrotic mechanisms associated with lymphedema, as well as new therapies that target inflammation and fibrosis.

Original language	English (US)
Title of host publication	Multimodal Management of Upper and Lower Extremity Lymphedema
Publisher	Springer International Publishing
Pages	209-213
Number of pages	5
ISBN (Electronic)	9783030930394
ISBN (Print)	9783030930387
DOIs	https://doi.org/10.1007/978-3-030-93039-4_27
State	Published - May 9 2022
Externally published	Yes

Keywords

Fibrosis
Inflammation
Lymphedema
Therapies

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-93039-4_27

Cite this

@inbook{910fd4edfa6242018db264a801c61fea,

title = "New and emerging therapies for lymphedema: Part II",

abstract = "The roles of inflammation, fibrosis, and adipose deposition in response to lymph stasis are critical to understanding the pathogenesis of lymphedema. This chapter reviews our current understanding of the key targets in the inflammatory and fibrotic mechanisms associated with lymphedema, as well as new therapies that target inflammation and fibrosis.",

keywords = "Fibrosis, Inflammation, Lymphedema, Therapies",

author = "Sibley, {Robert C.} and Rockson, {Stanley G.}",

year = "2022",

month = may,

day = "9",

doi = "10.1007/978-3-030-93039-4_27",

language = "English (US)",

isbn = "9783030930387",

pages = "209--213",

booktitle = "Multimodal Management of Upper and Lower Extremity Lymphedema",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - New and emerging therapies for lymphedema

T2 - Part II

AU - Sibley, Robert C.

AU - Rockson, Stanley G.

PY - 2022/5/9

Y1 - 2022/5/9

N2 - The roles of inflammation, fibrosis, and adipose deposition in response to lymph stasis are critical to understanding the pathogenesis of lymphedema. This chapter reviews our current understanding of the key targets in the inflammatory and fibrotic mechanisms associated with lymphedema, as well as new therapies that target inflammation and fibrosis.

AB - The roles of inflammation, fibrosis, and adipose deposition in response to lymph stasis are critical to understanding the pathogenesis of lymphedema. This chapter reviews our current understanding of the key targets in the inflammatory and fibrotic mechanisms associated with lymphedema, as well as new therapies that target inflammation and fibrosis.

KW - Fibrosis

KW - Inflammation

KW - Lymphedema

KW - Therapies

UR - http://www.scopus.com/inward/record.url?scp=85157962854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85157962854&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-93039-4_27

DO - 10.1007/978-3-030-93039-4_27

M3 - Chapter

AN - SCOPUS:85157962854

SN - 9783030930387

SP - 209

EP - 213

BT - Multimodal Management of Upper and Lower Extremity Lymphedema

PB - Springer International Publishing

ER -

New and emerging therapies for lymphedema: Part II

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this